An ongoing randomized controlled clinical trial (RCT) to test the role of Hydroxychloroquine (HCQ) in the treatment or prevention of COVID-19 was prematurely halted by the British scientists by calling it “Useless” as they found no evidence of any positive effects of this anti-malarial drug against the coronavirus (see below). The US Food and Drug …